Cilostazol vs. Aspirin for recent stroke with brain microbleeds
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial compares two medications—cilostazol and aspirin—to see which is better at preventing another stroke in people who have had a recent clot-caused stroke and also have tiny spots of bleeding in the brain (microbleeds). It aims to find a safer and more effective treatment for this specific group.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a stroke caused by a blood clot (not from your heart) within the last month.
- An MRI scan shows tiny spots of old bleeding in your brain, called microbleeds.
- You do not have a condition called cerebral amyloid angiopathy (CAA) that causes brain bleeding.
- You have not had a serious reaction to aspirin or cilostazol before.
- You are not taking a strong blood thinner or need two antiplatelet drugs for more than a month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if the drug cilostazol can prevent another stroke in people who have already had one. It is designed for patients in Africa and compares adding cilostazol to standard aspirin or clopidogrel therapy.
This study tests whether a combination of antiplatelet drugs and artery-stabilizing medication can improve recovery after a small stroke caused by damage to tiny blood vessels in the brain. It may help prevent further strokes and support healing.
This trial tests whether cilostazol, a medication that helps keep blood flowing, can prevent another stroke and slow down disease progression in people who have had a recent stroke caused by small vessel disease. It aims to stop the brain damage from getting worse.
This trial tests whether adding cilostazol or clopidogrel to aspirin is safe and effective for people who recently had a mild stroke or a transient ischemic attack (TIA) caused by a large artery blockage. It aims to prevent another stroke during the first 90 days.
This trial is testing whether combining aspirin with either cilostazol or clopidogrel is more effective at preventing another stroke after a minor stroke or TIA. It is for people who had their first mild stroke or TIA and started a blood thinner within 24 hours.
This trial tests whether the drug cilostazol can prevent delayed brain damage in people who have had bleeding from a brain aneurysm. It is for adults who had their aneurysm treated within 72 hours and are in moderate to serious condition.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.